Drug intelligence / Profile preview

ProstaCare

Development stage: Unknown
Lead developer: Ergon Pharmaceuticals
Administration: Oral

Overview

ProstaCare is an Ayurvedic herbal formulation developed by Ergon Pharmaceuticals for the management of prostate-related conditions, specifically Benign Prostatic Hyperplasia (BPH). It is marketed as a natural solution to improve urinary flow and reduce the discomfort associated with an enlarged prostate. As an Ayurvedic medicine, it utilizes a combination of traditional herbs known for their anti-inflammatory and diuretic properties. The product is currently approved and available on the market in Bangladesh.

Brand names: ProstaCare
Other names: PROSTA CARE

Beyond the preview

Go deeper on ProstaCare.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ProstaCare.

Explore the full profile